Clinical Trials

Find a Trial

Trial Results

11 protocol(s) meet the specified criteria
ARRAY-162-202OPEN TO ACCRUAL
An Open-label Phase 1b/2 Study of Binimetinib Administered in Combination with Nivolumab or Nivolumab Plus Ipilimumab in Patients with Previously Treated Microsatellite-stable (MSS) Metastatic Colorectal Cancer with RAS Mutation
ARRAY818-302OPEN TO ACCRUAL
The BEACON CRC Study (Binimetinib, Encorafenib, And Cetuximab COmbiNed to Treat BRAF-mutant ColoRectal Cancer): A Multicenter, Randomized, Open-label, 3-Arm Phase 3 Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA) /Irinotecan (FOLFIRI)/Cetuximab with a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients with BRAF V600E-mutant Metastatic Colorectal Cancer
IUSCC-0612OPEN TO ACCRUAL
Mindfulness to Enhance Quality of Life and Support Advance Care Planning (MEANING): A Randomized Controlled Pilot Trial for Adults with Metastatic Cancer and Their Family Caregivers
LCCC1317OPEN TO ACCRUAL
Genotype-directed Phase II Study of Irinotecan Dosing in Metastatic Colorectal Cancer (mCRC) Patients Receiving FOLFIRI + Bevacizumab
LCCC1632OPEN TO ACCRUAL
LCCC 1632: Phase II multicenter trial of panitumumab, nivolumab, and ipilimumab for KRAS/NRAS/BRAF wild-type MSS refractory metastatic colorectal adenocarcinoma
NRG-GI004OPEN TO ACCRUAL
Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study: A Randomized Phase III Study of mFOLFOX6/Bevacizumab Combination Chemotherapy with or without Atezolizumab or Atezolizumab Monotherapy in the First-Line Treatment of Patients with Deficient DNA Mismatch Repair (dMMR) Metastatic Colorectal Cancer
NURS-IIR-RAWL-PCORIOPEN TO ACCRUAL
Comparing Interventions to Increase Colorectal Cancer Screening in Low-Income and Minority Patients
SURG-CLINGEN-ROBB-NOVAOPEN TO ACCRUAL
Evaluation of the Performance of the Clinical Genomics Colvera Test in the Detection of Disease Recurrence in Patients Diagnosed with Colorectal Cancer
SURG-DUKE-CEPPA-VACOPEN TO ACCRUAL
A Randomized Phase II Evaluation of Negative Pressure Wound Therapy for Reduction of Postoperative Surgical Site Infection in Patients Undergoing Colorectal and Hepatopancreatobiliary Surgery
SURG-ETHICON-ROBB-ENSEALOPEN TO ACCRUAL
A Prospective, Multi-Center Evaluation of the ENSEAL X1 Large Jaw Tissue Sealer
SURG-LIFEB-FAJARDO-LSOPEN TO ACCRUAL
Efficacy and Safety of LifeSeal Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study